Clinical Trial Update: Immunogenicity and Safety of an Inactivated SARS-CoV-2 Vaccine Coadministered With Two Attenuated Vaccines [Phase 4]

View source ↗

Summary

Phase 4 trial updating immunogenicity and safety of an inactivated SARS-CoV-2 vaccine when coadministered with two attenuated vaccines, focusing on SARS-CoV-2 i…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Measles
• Mumps
• Rubella
• Varicella

Drugs mentioned

• attenuated vaccines (coadministered)
• inactivated SARS-CoV-2 vaccine

Snippet

Sponsor: Shanghai Municipal Center for Disease Control and Prevention | Conditions: SARS-CoV-2 Infection, Varicella | Phase 4 | Status: UNKNOWN